Home > Drug Search >
  • company_query: Alphaeon
  •   > 
Drug Filter
Category:
chemistry (3) biology (28)
Status:
Approved (6) BLA Filing (2) Phase Ⅱ (11) Phase Ⅰ (12)
Clinical Stage:
Pending (2) Active (22) Discontinued (1)
Bio-Type:
Cell therapy (1) CAR T cell therapy (1) Vaccine (8) Blood extraction (1) Microbial extract (2) Recombinant cytokines (2) Recombinant hormone (1) Whole antibody (4)
Indication:
Non-alcoholic steatohepatitis (1) Basal cell carcinoma (BCC) (1) Chronic lymphocytic leukemia (CLL) (1) Diabetic macular edema (1) Epidermolysis bullosa (1) Penile cancer (1) Follicular lymphoma (1) Growth hormone deficit (1) Alcoholic hepatitis (1) Blepharospasm (1) Glabellar line (2) Influenza virus infection (4) Leukemia (1) Lymphoma (1) Graves ophthalmopathy (1) Mantle cell lymphoma (MCL) (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (2) Post-polycythemia vera (1) Prostate cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (3) Rectal fistula (1) Solid tumours (1) Systemic lupus erythematosus (1) Hodgkin lymphoma (1) Primary humoral immunodeficiency (1) Neuroblastoma (1) Age-related macular degeneration (AMD) (1) Autistic disorder (1) Cervical carcinoma (1) Waldenström's macroglobulinemia (WM) (1) B-cell lymphoma (1) Neutropenia (1) Contraception (1) Growth failure (1) Pressure sore (1) Respiratory syncytial virus infection (1) Diffuse large B cell lymphoma (1) Ebola virus disease (EVD) (1) Sciatica (1) Inflammation (1) Human papillomavirus infections (HPV) (1) Immune thrombocytopenic purpura (1)
Country:
US (1) EU (1) CN (1)
Aprv. Year:
2009 (1) 2014 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top